The Effects of Chronic Exercise on UCP1 Gene in Human White Adipose Tissue
1 other identifier
interventional
32
1 country
1
Brief Summary
Obesity is characterized by excessive white adipose tissue (WAT) that increases risk for disease. About 700 million adults are obese worldwide, designating the need of reducing excessive WAT in humans and subsequently the risk for disease. For this reason, previous research focused on the thermogenic capacity of white adipocytes in response to chronic exercise. It is suggested that the latter occurs due to increased demand of oxidation during exercise to maintain non-esterified fatty acids flux in the circulation, thus to maintain energy supply White adipocytes express the uncoupling protein one (UCP1), which dissipates chemical energy in the mitochondria to produce heat in response to cold exposure. UCP1 was thought that exclusively appears in brown adipose tissue (BAT), which during the mitochondrial electron transport chain process, bypasses the adenosine triphosphate (ATP) synthase to produce heat, as a thermoregulatory mechanism of maintaining body temperature. Its presence in white adipocytes, indicates a thermogenic capacity of WAT, which could lead to similar health benefits as those reported for increased BAT activity; mainly reduced body mass index (BMI) and fat mass, which designate body weight loss and reduced obesity phenotype. The investigators aimed to identify whether UCP1 in human WAT is altered by chronic exercise.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2014
CompletedFirst Submitted
Initial submission to the registry
July 26, 2019
CompletedFirst Posted
Study publicly available on registry
July 31, 2019
CompletedJuly 31, 2019
July 1, 2019
12 months
July 26, 2019
July 30, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
UCP1 mRNA expression in white adipocytes
UCP1 mRNA expression was measured via fat biopsy samples from the subcutaneous abdominal area at baseline, at the end of the exercise intervention (8th week) and at the end of the de-training period (16th week)
Baseline measurements; measurements at the end of the exercise intervention (8th week); measurements at the end of the de-training period (16th week)
UCP1 protein concentration in white adipocytes
UCP1 protein concentration was measured via fat biopsy samples from the subcutaneous abdominal area at baseline, at the end of the exercise intervention (8th week) and at the end of the de-training period (16th week)
Baseline measurements; measurements at the end of the exercise intervention (8th week); measurements at the end of the de-training period (16th week)
Study Arms (4)
Aerobic exercise group
EXPERIMENTALResistance exercise group
EXPERIMENTALCombined (aerobic+resistance) exercise group
EXPERIMENTALNon-exercise group
NO INTERVENTIONInterventions
The investigators evaluated the effects of an eight weeks aerobic exercise program and a following of eight weeks of a de-training period on UCP1 gene in previously non-regular exercisers healthy adult men
The investigators evaluated the effects of an eight weeks resistance exercise program and a following of eight weeks of a de-training period on UCP1 gene in previously non-regular exercisers healthy adult men
The investigators evaluated the effects of an eight weeks combined (aerobic+resistance) exercise program and a following of eight weeks of a de-training period on UCP1 gene in previously non-regular exercisers healthy adult men
Eligibility Criteria
You may qualify if:
- adult men
- healthy
- no chronic disease
- no medication treatment
- no regular exercisers
You may not qualify if:
- women
- non-adult men
- chronic disease individuals
- any medication treatment
- acute illness
- regular exercisers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Petros Dinaslead
Study Sites (1)
Petros Dinas
Trikala, Thessaly, 42100, Greece
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Senior Researcher in human physiology
Study Record Dates
First Submitted
July 26, 2019
First Posted
July 31, 2019
Study Start
June 1, 2013
Primary Completion
May 30, 2014
Study Completion
June 30, 2014
Last Updated
July 31, 2019
Record last verified: 2019-07